Back to SNDX
Kynam Capital Management, LP → SNDX
Kynam Capital Management, LP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$153.2M
Q3 2026
Peak value
$188.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $169.2M |
| Q1 2026 | $188.1M |
| Q2 2026 | $176M |
| Q3 2026 | $153.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153.2M | 8.15M | — | — |
| Q2 2026 | $176M | 8.05M | — | — |
| Q1 2026 | $188.1M | 8.05M | — | — |
| Q4 2025 | $169.2M | 8.05M | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M